Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United States

Cardiovascular Risk and Diseases

Patterns of Telehealth Visits After the COVID-19 Pandemic Among Individuals With or at Risk for Cardiovascular Disease in the United States

J Am Heart Assoc

Bhatla A, Ding J, Mhaimeed O, Spaulding EM, Commodore-Mensah Y, Plante TB, Shan R, Marvel FA, Martin SS

doi: 10.1161/JAHA.124.036475

Further Publications

Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People

J Am Heart Assoc

Zoungas S, Moran C, Curtis AJ, Spark S, Flanagan Z, Beilin L, Chong TT, Cloud GC, Hopper I, Kost A, McNeil JJ, Nicholls SJ, Reid CM, Ryan J, Tonkin AM, Ward S, Wierzbicki AS, Wolfe R, Zhou Z, Nelson MR, STAREE investigator group

doi: 10.1161/JAHA.124.036357

Heart Failure

Management and outcomes of heart failure hospitalization among older adults in the United States and Japan

ESC Heart Fail

Bates BA, Enzan N, Tohyama T, Gandhi P, Matsushima S, Tsutsui H, Setoguchi S, Ide T

doi: 10.1002/ehf2.14873

Cardiovascular Risk and Diseases

Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)

Eur Heart J

Wilkinson C, Bhatty A, Batra G, Aktaa S, Smith AB, Dwight J, Ruciński M, Chappell S, Alfredsson J, Erlinge D, Ferreira J, Guðmundsdóttir IJ, Hrafnkelsdóttir ÞJ, Ingimarsdóttir IJ, Irs A, Jánosi A, Járai Z, Oliveira-Santos M, Popescu BA, Vasko P, Vinereanu D, Yap J, Bugiardini R, Cenko E, Nadarajah R, Sydes MR, James S, Maggioni AP, Wallentin L, Casadei B, Gale CP, Global Cardiovascular Outcomes Consortium and in collaboration with ACNAP, ACVC, EACVI, EAPC, EAPCI, EHRA, ESC Committee for Young CV Professionals, ESC Registry Committee, HFA, ESC Patient Forum and these Working Groups: aorta and peripheral vascular diseases, atherosclerosis and vascular biology, cardiac cellular electrophysiology, cardiovascular pharmacotherapy, cardiovascular regenerative and restorative medicine, cardiovascular surgery, cellular biology of the heart, e-cardiology, myocardial function, pulmonary circulation and right ventricular function and thrombosis

doi: 10.1093/eurheartj/ehae724

Heart Failure

Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC

Eur J Heart Fail

Gorenek B, Wijnmaalen AP, Goette A, Mert GO, Porter B, Gustafsson F, Dan GA, Ector J, Stuehlinger M, Spartalis M, Gosau N, Amir O, Chioncel O

doi: 10.1002/ejhf.3645

Cardiac Arrest or Death

Survival Outcomes After Sudden Cardiac Arrest in Young Competitive Athletes From the United States

J Am Coll Cardiol

Petek BJ, Churchill TW, Moulson N, Delong R, Minnig MC, Kliethermes SA, Baggish AL, Maleszewski JJ, Kucera KL, Harmon KG, Drezner JA

doi: 10.1016/j.jacc.2025.03.006

Further Publications

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial

JAMA Cardiol

Benziger CP, Stebbins A, Wruck LM, Effron MB, Marquis-Gravel G, Farrehi PM, Girotra S, Gupta K, Kripalani S, Munoz D, Polonsky TS, Sharlow A, Whittle J, Harrington RA, Rothman RL, Hernandez AF, Jones WS

doi: 10.1001/jamacardio.2024.1712

Cardiovascular Risk and Diseases

Associations of carbohydrate quality and cardiovascular risk factors vary among diabetes subtypes

Cardiovasc Diabetol

Weber KS, Schlesinger S, Goletzke J, Straßburger K, Zaharia OP, Trenkamp S, Wagner R, Lieb W, Buyken AE, Roden M, Herder C, GDS group

doi: 10.1186/s12933-025-02580-4

Cardiovascular Risk and Diseases

Outcome Prediction After Tetralogy of Fallot Repair: A Prospective Clinical and Cardiovascular Magnetic Resonance Study

J Am Heart Assoc

Wald RM, Tomlinson G, Caldarone CA, Dahdah N, Dallaire F, Drolet C, Farkouh ME, Grewal J, Hancock-Friesen C, Hickey EJ, Karur GR, Keir M, Kovacs AH, Leonardi B, McCrindle BW, Nadeem SN, Ng MY, Samuel M, Shah A, Tham EB, Therrien J, Van De Bruaene A, Vonder Muhll IF, Warren AE, Yamamura K, Khairy P

doi: 10.1161/JAHA.124.039006

Related content

Patterns of Telehealth Visits After the COVID-19 Pandemic Among Individuals With or at Risk for Cardiovascular Disease in the United States

Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People

Management and outcomes of heart failure hospitalization among older adults in the United States and Japan

Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)

Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC

Survival Outcomes After Sudden Cardiac Arrest in Young Competitive Athletes From the United States

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial

Associations of carbohydrate quality and cardiovascular risk factors vary among diabetes subtypes

Outcome Prediction After Tetralogy of Fallot Repair: A Prospective Clinical and Cardiovascular Magnetic Resonance Study